檢測法市場：按產品、技術、用途和最終用戶分類 - 2023-2030 年全球預測

全球檢測法市場預計將在 2023 年大幅成長至 255.5 億美元，複合年成長率為 7.17%，預計到 2030 年將達到驚人的 415.7 億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球檢測法市場至關重要。透過檢查業務策略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的特定需求做出明智的資訊。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發領域、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1.檢測法的全球市場規模與預測為何？

2.在預測期內，COVID-19 對全球檢測法市場的阻礙因素和影響為何？

3. 在預測期內，全球檢測法市場需要投資哪些產品/細分市場/用途/領域？

4. 你們在全球檢測法市場的競爭策略是什麼？

5. 全球檢測法市場的技術趨勢和法律規範是什麼？

6.全球檢測法市場主要廠商的市佔率為何？

7. 哪些型態和策略措施被認為適合進入全球檢測法市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

• 市場動態
  • 促進因素
    • 慢性病和感染疾病的增加以及早期診斷的好處
    • 在分散的醫療服務環境中對快速診斷測試的需求不斷增加
    • 擴大多重檢測檢測法技術在藥物研發的應用
  • 抑制因素
    • 與檢測法標準化相關的問題
  • 機會
    • 自動化設備和裝置數量的技術進步
    • 加速免疫分析在腫瘤學以及藥物和酒精檢測的應用
  • 任務
    • 政府嚴格法規場景
• 市場趨勢
• COVID-19 的累積影響
• 俄羅斯-烏克蘭衝突的累積影響
• 高通膨的累積效應
• 波特五力分析
• 價值鍊和關鍵路徑分析
• 法律規範
• 客戶客製化

第6章 檢測法市場：副產品

• 介紹
• 分析儀
• 消耗品

第7章 檢測法市場：依技術分類

• 介紹
• 化學發光檢測法
• 酶聯螢光測定
• 酵素免疫分析法
• 放射免疫分析法

第8章 檢測法市場：依用途

• 介紹
• 心臟病學
• 內分泌學
• 感染疾病
• 腫瘤學
• 整形外科

第9章 檢測法市場：依最終用戶分類

• 介紹
• 血庫
• 診斷實驗室
• 醫院

第10章 美洲檢測法市場

• 介紹
• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美國

第11章亞太免疫檢測法市場

• 介紹
• 澳洲
• 中國
• 印度
• 印尼
• 日本
• 馬來西亞
• 菲律賓
• 新加坡
• 韓國
• 台灣
• 泰國
• 越南

第12章歐洲、中東和非洲檢測法市場

• 介紹
• 丹麥
• 埃及
• 芬蘭
• 法國
• 德國
• 以色列
• 義大利
• 荷蘭
• 奈及利亞
• 挪威
• 波蘭
• 卡達
• 俄羅斯
• 沙烏地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公國
• 英國

第13章競爭形勢

• FPNV定位矩陣
• 市佔率分析：主要企業
• 競爭情境分析：主要企業

第14章上市公司名單

第15章附錄

• 討論指南
• 關於許可證和定價

The Global Immunoassay Market is forecasted to grow significantly, with a projected USD 25.55 billion in 2023 at a CAGR of 7.17% and expected to reach a staggering USD 41.57 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Immunoassay Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Immunoassay Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Analyzer and Consumables. The Consumables is projected to witness significant market share during forecast period.

Based on Technology, market is studied across Chemiluminescence Immunoassay, Enzyme-linked Fluorescence Assay, Enzyme-linked Immunosorbent Assay, and Radioimmunoassay. The Enzyme-linked Immunosorbent Assay is projected to witness significant market share during forecast period.

Based on Application, market is studied across Cardiology, Endocrinology, Infectious Disease, Oncology, and Orthopedics. The Infectious Disease is projected to witness significant market share during forecast period.

Based on End User, market is studied across Blood Banks, Diagnostics Laboratories, and Hospitals. The Hospitals is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Immunoassay Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Immunoassay Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Immunoassay Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Immunoassay Market?

4. What is the competitive strategic window for opportunities in the Global Immunoassay Market?

5. What are the technology trends and regulatory frameworks in the Global Immunoassay Market?

6. What is the market share of the leading vendors in the Global Immunoassay Market?

7. What modes and strategic moves are considered suitable for entering the Global Immunoassay Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Immunoassay Market, by Product, 2022 vs 2030
• 4.3. Immunoassay Market, by Technology, 2022 vs 2030
• 4.4. Immunoassay Market, by Application, 2022 vs 2030
• 4.5. Immunoassay Market, by End User, 2022 vs 2030
• 4.6. Immunoassay Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising chronic and infectious diseases and benefits of early diagnosis
    • 5.1.1.2. Growing demand for rapid diagnostic tests in decentralized healthcare delivery settings
    • 5.1.1.3. Expanding application of multiplex detection immunoassay technique in drug development
  • 5.1.2. Restraints
    • 5.1.2.1. Issues with immunoassay standardization
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements in the number of automated instruments and equipment
    • 5.1.3.2. Accelerating use of immunoassays in oncology and drug & alcohol testing
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent government regulatory scenario
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Immunoassay Market, by Product

• 6.1. Introduction
• 6.2. Analyzer
• 6.3. Consumables

7. Immunoassay Market, by Technology

• 7.1. Introduction
• 7.2. Chemiluminescence Immunoassay
• 7.3. Enzyme-linked Fluorescence Assay
• 7.4. Enzyme-linked Immunosorbent Assay
• 7.5. Radioimmunoassay

8. Immunoassay Market, by Application

• 8.1. Introduction
• 8.2. Cardiology
• 8.3. Endocrinology
• 8.4. Infectious Disease
• 8.5. Oncology
• 8.6. Orthopedics

9. Immunoassay Market, by End User

• 9.1. Introduction
• 9.2. Blood Banks
• 9.3. Diagnostics Laboratories
• 9.4. Hospitals

10. Americas Immunoassay Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Immunoassay Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Immunoassay Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. FPNV Positioning Matrix
• 13.2. Market Share Analysis, By Key Player
• 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

• 15.1. Discussion Guide
• 15.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. IMMUNOASSAY MARKET RESEARCH PROCESS
• FIGURE 2. IMMUNOASSAY MARKET SIZE, 2022 VS 2030
• FIGURE 3. IMMUNOASSAY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
• FIGURE 5. IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
• FIGURE 6. IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
• FIGURE 7. IMMUNOASSAY MARKET SIZE, BY END USER, 2022 VS 2030 (%)
• FIGURE 8. IMMUNOASSAY MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 9. IMMUNOASSAY MARKET DYNAMICS
• FIGURE 10. IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. IMMUNOASSAY MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES IMMUNOASSAY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 18. IMMUNOASSAY MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 19. IMMUNOASSAY MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. IMMUNOASSAY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. IMMUNOASSAY MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 5. IMMUNOASSAY MARKET SIZE, BY ANALYZER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 8. IMMUNOASSAY MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. IMMUNOASSAY MARKET SIZE, BY ENZYME-LINKED FLUORESCENCE ASSAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. IMMUNOASSAY MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. IMMUNOASSAY MARKET SIZE, BY RADIOIMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 13. IMMUNOASSAY MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. IMMUNOASSAY MARKET SIZE, BY ENDOCRINOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. IMMUNOASSAY MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. IMMUNOASSAY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. IMMUNOASSAY MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 19. IMMUNOASSAY MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. IMMUNOASSAY MARKET SIZE, BY DIAGNOSTICS LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. IMMUNOASSAY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 35. CANADA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 36. CANADA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 37. CANADA IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. CANADA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES IMMUNOASSAY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 53. AUSTRALIA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. AUSTRALIA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 55. AUSTRALIA IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 57. CHINA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 58. CHINA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 59. CHINA IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. CHINA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 61. INDIA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. INDIA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 63. INDIA IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. INDIA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 65. INDONESIA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. INDONESIA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 67. INDONESIA IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. INDONESIA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 69. JAPAN IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. JAPAN IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 71. JAPAN IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. JAPAN IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 73. MALAYSIA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. MALAYSIA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 75. MALAYSIA IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. MALAYSIA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 77. PHILIPPINES IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. PHILIPPINES IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 79. PHILIPPINES IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. PHILIPPINES IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 81. SINGAPORE IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. SINGAPORE IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 83. SINGAPORE IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. SINGAPORE IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH KOREA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH KOREA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH KOREA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 89. TAIWAN IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. TAIWAN IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 91. TAIWAN IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. TAIWAN IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 93. THAILAND IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 94. THAILAND IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 95. THAILAND IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. THAILAND IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 97. VIETNAM IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 98. VIETNAM IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 99. VIETNAM IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. VIETNAM IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 101. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 106. DENMARK IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 107. DENMARK IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 108. DENMARK IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. DENMARK IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 110. EGYPT IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 111. EGYPT IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 112. EGYPT IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. EGYPT IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 114. FINLAND IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 115. FINLAND IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 116. FINLAND IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. FINLAND IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 118. FRANCE IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 119. FRANCE IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 120. FRANCE IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. FRANCE IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 122. GERMANY IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 123. GERMANY IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 124. GERMANY IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. GERMANY IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 126. ISRAEL IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 127. ISRAEL IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 128. ISRAEL IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. ISRAEL IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 130. ITALY IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 131. ITALY IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 132. ITALY IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. ITALY IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 134. NETHERLANDS IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 135. NETHERLANDS IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 136. NETHERLANDS IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. NETHERLANDS IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 138. NIGERIA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 139. NIGERIA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 140. NIGERIA IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. NIGERIA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 142. NORWAY IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 143. NORWAY IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 144. NORWAY IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. NORWAY IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 146. POLAND IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 147. POLAND IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 148. POLAND IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 149. POLAND IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 150. QATAR IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 151. QATAR IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 152. QATAR IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 153. QATAR IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 154. RUSSIA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 155. RUSSIA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 156. RUSSIA IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 157. RUSSIA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 158. SAUDI ARABIA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 159. SAUDI ARABIA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 160. SAUDI ARABIA IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 162. SOUTH AFRICA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH AFRICA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH AFRICA IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 166. SPAIN IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 167. SPAIN IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 168. SPAIN IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 169. SPAIN IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 170. SWEDEN IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 171. SWEDEN IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 172. SWEDEN IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 173. SWEDEN IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 174. SWITZERLAND IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 175. SWITZERLAND IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 176. SWITZERLAND IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 177. SWITZERLAND IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 178. TURKEY IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 179. TURKEY IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 180. TURKEY IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 181. TURKEY IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 182. UNITED ARAB EMIRATES IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 183. UNITED ARAB EMIRATES IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 184. UNITED ARAB EMIRATES IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 186. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 187. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 188. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 190. IMMUNOASSAY MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 191. IMMUNOASSAY MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 192. IMMUNOASSAY MARKET LICENSE & PRICING